Abstract
Few pharmaceutical markets will see the dramatic change that will occur in
cancer therapeutics over the next four years. More than $8 billion dollars
worth of new products are expected in the next four years, impacting the
treatment of cancer in ways that product managers, strategic planners,
business development managers and marketing executives will need to be aware
of.
Between 2004 and 2006, the market for cancer therapeutics saw more than an 18%
increase, presaging future growth. Given the promising therapy pipeline and
increasing incidence of cancer, double-digit growth is expected annually,
leading to opportunities for current players and new entrants alike.
Kalorama' s Cancer Therapeutics: The Worldwide Market is your guide to a $45
billion dollar cancer treatment market that is expected to double in the next
four years.
Kalorama' s detailed report includes the following:
- Current Market Size and Revenue Forecasts for each market segment for
long-term strategic business planning.
- Round-Up of the Key Players in the Cancer Therapeutics Market
- The Collective Market Knowledge of over 65 Market Insiders interviewed for
this report.
- Identification of the Fastest Growing Areas of Cancer Therapy so that
marketers can make strategic adjustments or consider new products.
- Over 160 Tables and Figures for decision support and internal emails,
memos and presentations.
- Discussion of 17 Issues and Trends critical to understanding this Market
and assessing opportunities.
In this second edition, Kalorama builds on the success of the first edition of
Cancer Therapeutics: The Worldwide Market, which correctly anticipated the
growth of this market over the previous years. Since the last edition, there' s
been more changes in cancer treatment, especially in the area of
immunobiological treatments for cancer. Kalorama details that change in this
edition.
This study breaks down the cancer therapeutics market by therapy type, reporting and forecasting revenues from 2004 through 20011 in the following area:
- Chemotherapy
- Hormone Therapy
- Radiation Therapy
- Immunotherapy and Biotherapy, and
- Adjunctive Therapies
A truly global report, The Worldwide Market for Cancer Therapeutics breaks
down the market for cancer therapeutics in the United States, Europe, Japan
and the Rest of the World in detail.
The study focuses on current and emerging markets, products in development,
and trends affecting the cancer treatment market. Demographic and
epidemiological data are presented for the major cancer types, therapies in
development are reviewed by development stage and earliest possible approval
date, and profiles of the leading and significant competitors are included
for reference.
- Bladder
- Breast
- Cervical
- Colorectal
- Esophageal
- Head/Neck
- Kidney
- Leukemia
- Liver
- Lung
- Lymphoma
- Melanoma
- Multiple Myeloma
- Neuroblastoma
- Ovarian
- Pancreatic
- Prostate
- Stomach
As part of Kalorama' s trusted information-gatehring process, information for
this report is drawn from company reports, government data and medical
journals, then checked and cross-referenced extensively with experts in the
cancer therapeutics industry. Interviews are the main source of market
insights and forecasts.
Companies covered in this exhaustive report include:
- Amgen
- AstraZeneca plc
- Biogen IDEC, Inc.
- Bristol-Myers Squibb Company/Oncology
- Eli Lilly & Company
- Genentech, Inc.
- GlaxoSmithKline plc
- Johnson & Johnson Group
- Merck & Company, Inc.
- Novartis Pharmaceuticals
- Pfizer, Inc.
- Roche
- Sanofi-Aventis
- Schering-Plough
- TAP Pharmaceutical Products
| 
View Cart
